Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation
about
Inflammation-inducing Factors of Mycoplasma pneumoniaeAnalysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxinNovel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implicationsVariation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniaeIntranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumoniaRespiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.Mycoplasma pneumoniae from the Respiratory Tract and Beyond.Increased Serum Interleukin-10 but not Interleukin-4 Level in Children with Mycoplasma pneumoniae Pneumonia.Mycoplasma pneumoniae-derived lipopeptides induce acute inflammatory responses in the lungs of mice.High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia
P2860
Q26749594-27C4CD48-C945-437E-9E5F-BBA90B888ABAQ33512911-E50D18BE-E67B-43DF-A296-A29191DBC685Q34023899-7A5862BF-1131-4462-B427-A104394F5FD9Q34172141-CB060F8C-6942-4073-8B71-2E5E27DF2557Q34437813-5F535039-C16A-495C-A1AD-105155681D1EQ36421600-F3B7BA6A-9F0C-41C2-B858-505E49E86B57Q36710729-79B9A8C2-1DCA-4DDB-96B5-0239BAFB6CF6Q36924030-92CB7F7E-FE14-4A82-90DA-D51036B75D3BQ37144834-8B1B7306-BEA9-4489-A0C2-4C11DD676A1EQ39327219-39464E1B-DF13-45ED-BA5E-EB098B75C2AFQ40383519-04338CB7-E63E-4A9D-8020-A7F91FD4E39CQ41911556-4CEC9AAE-4C0E-44FD-836A-D560A6C94850Q58695168-5226E3A8-30B6-42F6-9C6B-01B9244E259B
P2860
Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Respiratory tract infection wi ...... reduced pulmonary inflammation
@ast
Respiratory tract infection wi ...... reduced pulmonary inflammation
@en
type
label
Respiratory tract infection wi ...... reduced pulmonary inflammation
@ast
Respiratory tract infection wi ...... reduced pulmonary inflammation
@en
prefLabel
Respiratory tract infection wi ...... reduced pulmonary inflammation
@ast
Respiratory tract infection wi ...... reduced pulmonary inflammation
@en
P2093
P2860
P356
P1476
Respiratory tract infection wi ...... reduced pulmonary inflammation
@en
P2093
C M Salvatore
G H McCracken
K Katz-Gaynor
M Fonseca-Aten
S Chavez-Bueno
P2860
P304
P356
10.1128/IAI.01249-06
P407
P577
2006-10-30T00:00:00Z